Mobile Menu

Search Results

Search results for: Biomarkers

Predicting biomarkers for immunotherapy response using machine learning

The complex nature of the tumour microenvironment poses a great challenge for the extraction of biomarkers of immune response and […]

Biomarkers Linked to Severe COVID-19 Infection

Researchers from the CHUM Research Centre have used data-driven and hypothesis-driven approaches to identify biomarkers that have been linked to […]

Genomics in Drug Discovery ONLINE – May 2022

Join us for Genomics in Drug Discovery ONLINE, a unique 3-part webinar series, where we explore the role of genetics […]

Omics in Drug Discovery ONLINE

With drug discovery being an expensive process and genetic-based drugs being more likely to succeed, the level of investment in […]

Data-driven eligibility criteria may make clinical trials more inclusive

Researchers have shown that relaxing the eligibility criteria of clinical trials in a data-driven manner can significantly increase the number […]

Artificial intelligence can identify the most effective targeted therapies for cancer patients

An artificial intelligence-based model has been used to match molecularly targeted agents (MTAs) to individual molecular tumour profiles, in the […]

Artificial intelligence has been used to identify network-based links between COVID-19 and Alzheimer’s disease

Researchers have used artificial intelligence to investigate network-based relationships between COVID-19 and Alzheimer’s disease, in the hope of informing therapeutic […]

Could Translational Precision Medicine be the modern approach to drug discovery and development?

A recent study has explored the concept of a modern and collaborative approach to data-driven drug development called Translational Precision […]

Modelling Alzheimer’s Disease Progression to Simulate Intervention Strategies

A recent study presented SimulAD, a novel computational model of Alzheimer’s disease progression, which simulates intervention strategies for treatment of […]

Surrogate Endpoint Evaluation Methodology

Robust identification of clinical trial surrogate end points can help to accelerate the development of pharmacotherapies for diseases that are […]